HK59984A - A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer - Google Patents

A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer

Info

Publication number
HK59984A
HK59984A HK599/84A HK59984A HK59984A HK 59984 A HK59984 A HK 59984A HK 599/84 A HK599/84 A HK 599/84A HK 59984 A HK59984 A HK 59984A HK 59984 A HK59984 A HK 59984A
Authority
HK
Hong Kong
Prior art keywords
ray contrast
contrast agent
physiologically acceptable
solutions
buffer
Prior art date
Application number
HK599/84A
Other languages
English (en)
Inventor
Bernhard Rakli Fridtjov
James Kelly Michael
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of HK59984A publication Critical patent/HK59984A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HK599/84A 1978-07-04 1984-08-02 A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer HK59984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7828764 1978-07-04
KR1019790002214A KR830001643B1 (ko) 1978-07-04 1979-07-03 X-선 조영제의 생리적으로 허용되는 멸균 주사용 용액을 제조하는 방법

Publications (1)

Publication Number Publication Date
HK59984A true HK59984A (en) 1984-08-10

Family

ID=26268114

Family Applications (1)

Application Number Title Priority Date Filing Date
HK599/84A HK59984A (en) 1978-07-04 1984-08-02 A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer

Country Status (22)

Country Link
US (2) US4278654A (fr)
JP (1) JPS5531068A (fr)
KR (1) KR830001643B1 (fr)
AR (1) AR222337A1 (fr)
AT (1) AT371998B (fr)
AU (1) AU523295B2 (fr)
BE (1) BE877443A (fr)
CA (1) CA1132901A (fr)
CH (1) CH649469A5 (fr)
DE (1) DE2926850C2 (fr)
DK (1) DK155714C (fr)
ES (1) ES482131A0 (fr)
FI (1) FI75492C (fr)
FR (1) FR2435253A1 (fr)
HK (1) HK59984A (fr)
IT (1) IT1193761B (fr)
NL (1) NL183121C (fr)
NZ (1) NZ190907A (fr)
PT (1) PT69869A (fr)
SE (1) SE445971B (fr)
SG (1) SG5784G (fr)
ZA (1) ZA793313B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150916A1 (de) * 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel"
US4396598A (en) * 1982-01-11 1983-08-02 Mallinckrodt, Inc. Triiodoisophthalamide X-ray contrast agent
WO1987000757A1 (fr) * 1985-08-09 1987-02-12 Cook Imaging, Inc. Milieux de constraste non-ioniques a base de polyol obtenus a partir de milieux de contraste ioniques
US5035877A (en) * 1985-08-09 1991-07-30 Cook Imaging Corporation Non-ionic contrast media from ionic contrast media
US4718463A (en) * 1985-12-20 1988-01-12 Mallinckrodt, Inc. Method of producing prefilled sterile plastic syringes
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US5847009A (en) 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US4863714A (en) * 1987-02-05 1989-09-05 Cook Imaging Corporation Sterilization of compositions of limited stability
IL94718A (en) * 1989-07-05 1994-10-21 Schering Ag Carboxamide non-ionic contrast media and method for the preparation thereof
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
US5191120A (en) * 1989-12-13 1993-03-02 Mallinckrodt Medical, Inc. Process for preparing nonionic X-ray contrast agents
US5075502A (en) * 1989-12-13 1991-12-24 Mallinckrodt, Inc. Nonionic x-ray contrast agents, compositions and methods
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
DE4316722A1 (de) * 1993-05-19 1994-11-24 Fresenius Ag Parenteral verabreichbare, unter Hitzesterilisationsbedingungen stabile O/W-Emulsion eines Röntgenkontrastmittels
PL328199A1 (en) 1996-01-25 1999-01-18 Schering Ag Improved concentrated intravascular injection and infusion solutions
DE19648650C2 (de) * 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
US6072069A (en) * 1998-11-04 2000-06-06 Biophysica, Inc. Biodegradable nonionic contrast media
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조
EP2854531A4 (fr) * 2012-05-30 2016-03-23 Verrow Pharmaceuticals Inc Formulations stabilisées contenant des agents de contraste iodés et des cyclodextrines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3758E (fr) * 1905-02-21 Jules Cesar Napoleon Fouilloy Collier d'attache pour protecteur antidérapant de pneumatiques
NL127881C (fr) * 1963-03-25
GB1069437A (en) * 1963-10-23 1967-05-17 Nyegaard & Co As Injectable x-ray contrast media
US3733397A (en) * 1966-12-02 1973-05-15 Pharmacia Ab Method for the x-ray visualization of body cavities and a preparation for carrying out the method
SE315975B (fr) * 1967-12-28 1969-10-13 Pharmacia Ab
US4021481A (en) * 1969-06-27 1977-05-03 Nyegaard & Co. A/S Amido derivatives of 2,4,6-triiodobenzoic acids containing at least one N-hydroxyalkyl and at least two hydroxyl groups
GB1321591A (en) * 1969-06-27 1973-06-27 Nyegaard & Co As Non-ionic iodinated x-ray contrast agents
CH583562A5 (fr) * 1973-07-17 1977-01-14 Bracco Ind Chimica Spa
GB1495679A (en) * 1974-06-17 1977-12-21 Mallinckrodt Inc Substituted isophthalamic acids
US3953497A (en) * 1974-07-29 1976-04-27 Mallinckrodt, Inc. 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof
GB1514920A (en) * 1974-10-09 1978-06-21 Reckitt & Colmann Prod Ltd Dispensing container for medicinal foams
FI760068A7 (fr) * 1975-02-03 1976-08-04 Schering Ag
DE2505218A1 (de) * 1975-02-05 1976-08-19 Schering Ag Neue orale roentgenkontrastmittel und verfahren zu ihrer herstellung
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same

Also Published As

Publication number Publication date
JPS5531068A (en) 1980-03-05
US4396597A (en) 1983-08-02
NZ190907A (en) 1981-10-19
DE2926850C2 (de) 1985-01-24
DK280979A (da) 1980-01-05
DK155714C (da) 1989-10-30
ATA464479A (de) 1983-01-15
AT371998B (de) 1983-08-25
NL183121C (nl) 1988-08-01
FR2435253A1 (fr) 1980-04-04
FI75492B (fi) 1988-03-31
NL183121B (nl) 1988-03-01
SE7905830L (sv) 1980-01-05
ZA793313B (en) 1980-08-27
US4278654A (en) 1981-07-14
IT7949618A0 (it) 1979-07-03
ES8200082A1 (es) 1980-12-16
CH649469A5 (de) 1985-05-31
FI75492C (fi) 1988-07-11
DE2926850A1 (de) 1980-03-06
FR2435253B1 (fr) 1984-03-16
IT1193761B (it) 1988-08-24
SG5784G (en) 1985-02-01
JPS6210209B2 (fr) 1987-03-05
PT69869A (en) 1979-08-01
KR830001643B1 (ko) 1983-08-22
BE877443A (fr) 1980-01-03
SE445971B (sv) 1986-08-04
AU523295B2 (en) 1982-07-22
NL7905166A (nl) 1980-01-08
FI792101A7 (fi) 1980-01-05
AU4861579A (en) 1980-02-07
ES482131A0 (es) 1980-12-16
AR222337A1 (es) 1981-05-15
DK155714B (da) 1989-05-08
KR830000911A (ko) 1983-04-28
CA1132901A (fr) 1982-10-05

Similar Documents

Publication Publication Date Title
ES8200082A1 (es) Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina.
DE69033600D1 (de) Verfahren zur Isolierung von Haemopnilus influenzae Protein-E
PH23256A (en) A process for the preparation of quinolone carboxylic acid derivatives
ZA868981B (en) An agent for the determination of peroxidase activity,with stabilizer,a process for its preparation and its use
PT76495B (en) Process for preparing new imidazolphenyl-tetrahydropyridazines
ATE56139T1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
NL7903352A (nl) Werkwijze ter bereiding van cyclohexaancarbonzuur- derivaten, alsmede werkwijze ter bereiding van farma- ceutische preparaten ermede.
GB1218460A (en) Lupus erythematosus skin test composition and its preparation
MX164795B (es) Inactivacion mediante fenoles del virus de la inmunodeficiencia humana(hiv),en soluciones con contenido de proteinas
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
ATE15030T1 (de) Verfahren zur herstellung von halogeno-anilinen.
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
SU1515606A1 (ru) Способ очистки и выделения нитропруссида натрия
UA13475A (uk) СПОСІБ ОДЕРЖАННЯ 6-БЕНЗИЛОКСИЗАМІЩЕНИХ ІЗОПРОПІЛОВИХ ЕФІРІВ beta-КАРБОЛІН-3-КАРБОНОВОЇ КИСЛОТИ
JPS5697222A (en) Injectable aqueous solutions and their manufacture
JPS5637195A (en) Method of unsealing envelope and composition used for said method
ES8107191A1 (es) Procedimiento para la preparacion de 2-(2-cloro-4-ciclopro- pil-fenil-imino)-imidazolidina
GEP19960537B (en) Method of inducing male sterility in cotton plants
DE3362239D1 (en) Process for preparing 3-alpha,7-beta-dihydroxy-5-beta-cholanic acid
HU9201315D0 (en) Process for the production of medical preparations containing 4-/n,n-dibenzyl-amino/-butyric acid or butyric amid as active agent, or their medically useful salts
GB806950A (en) Production of pharmaceutical preparations
GB1515487A (en) Process for the preparation of silage

Legal Events

Date Code Title Description
PE Patent expired